BaseSpace
Correlation Engine 2.0
Import Your Data
Literature

FAQ

More FAQs

Back to top
Clear Search sequence regions
(e.g. MYC, G-protein-coupled receptor binding, Inflammatory disorder, Kidney, Tamoxifen)
Bookmark Forward

Pharmacokinetics of Ro 23-6240 (AM 833), a new trifluorinated quinolone.

E Weidekamm, K Stöckel, D Dell

F. Hoffmann-La Roche & Co. Ltd., Department of Clinical Research and Pharmaceutical Research, Basel, Switzerland.

Chemioterapia : international journal of the Mediterranean Society of Chemotherapy 1987 Jun


filter terms:
  • administration oral (1)
  • am 833 (1)
  • anti infective agents (2)
  • biological availability (1)
  • ciprofloxacin (2)
  • fleroxacin (2)
  • half life (1)
  • humans (1)
  • infusions intravenous (1)
  • metabolic clearance rate (1)
  • pharmacokinetics (1)
  • ro 23-6240 (1)
    • Sizes of these terms reflect their relevance to your search.

    No abstract available.

    Citation

    E Weidekamm, K Stöckel, D Dell. Pharmacokinetics of Ro 23-6240 (AM 833), a new trifluorinated quinolone. Chemioterapia : international journal of the Mediterranean Society of Chemotherapy. 1987 Jun;6(2 Suppl):307-8

    Expand section icon Mesh Tags

    Expand section icon Substances


    PMID: 3151346

    View Full Text
    • Copyright © 2024 Illumina Inc. All rights reserved.